Weiwei Xie Selected Research

Weiwei Xie Research Topics

Disease

9	Neoplasms (Cancer) 02/2024 - 09/2016
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2019
3	Aneuploidy (Aneuploid) 01/2016 - 06/2013
2	Amyloidosis 08/2023 - 01/2021
2	Inflammation (Inflammations) 01/2018 - 10/2016
2	Trisomy (Trisomies) 01/2016 - 04/2014
1	Retinoblastoma (Glioblastoma, Retinal) 02/2024
1	Conversion Disorder (Astasia Abasia) 02/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Paraproteinemias (Monoclonal Gammopathy) 08/2023
1	COVID-19 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Diabetes Complications 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Cytomegalovirus Infections (Inclusion Disease) 01/2023
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023
1	Central Nervous System Vasculitis 01/2023
1	Wounds and Injuries (Trauma) 10/2022
1	Surgical Wound Infection 10/2022
1	Capsule Opacification 01/2022
1	Cataract (Cataracts) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Immunoglobulin Light-chain Amyloidosis 01/2021
1	Multiple Myeloma 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Bradycardia 12/2019
1	Infections 06/2019
1	Necrosis 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Cerebral Infarction 01/2018
1	Autism Spectrum Disorder 01/2018
1	Burnett Schwartz Berberian syndrome 01/2018
1	AIDS-Related Complex (ARC) 10/2017
1	Heart Failure 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Dehydration (Water Stress) 10/2016
1	Adenocarcinoma of Lung 09/2016
1	Deafness (Deaf Mutism) 12/2014
1	Down Syndrome (Down's Syndrome) 04/2014

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 06/2013
3	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2021 - 01/2019
3	Heterogeneous-Nuclear Ribonucleoprotein Group F-HIBA 01/2021 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 08/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2019
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 09/2016
1	N-methyladenosineIBA 02/2024
1	hydroxide ionIBA 02/2024
1	Oxygen (Dioxygen)IBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	DiglyceridesIBA 01/2023
1	LipidsIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	CytokinesIBA 01/2023
1	Jagged-1 ProteinIBA 01/2022
1	Transcription Factor 4IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Toll-Like Receptor 3IBA 01/2022
1	AntibodiesIBA 01/2020
1	LigandsIBA 01/2020
1	AntigensIBA 01/2020
1	VaccinesIBA 01/2020
1	InterferonsIBA 01/2020
1	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 12/2019
1	3' Untranslated Regions (3' UTR)IBA 07/2019
1	Messenger RNA (mRNA)IBA 07/2019
1	NucleotidesIBA 06/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	norcantharidinIBA 01/2019
1	Superoxide DismutaseIBA 01/2018
1	DNA HelicasesIBA 01/2018
1	Malondialdehyde (Propanedial)IBA 01/2018
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	NiobiumIBA 10/2017
1	Nonprescription Drugs (Patent Medicines)IBA 01/2017
1	wenxin keliIBA 01/2017
1	DiterpenesIBA 10/2016
1	KetonesIBA 10/2016
1	oridoninIBA 10/2016
1	Kaurane DiterpenesIBA 10/2016
1	apatinibIBA 09/2016
1	dichlorobis(azomycin)platinum IIIBA 01/2016

Therapy/Procedure

1	Electrodes (Electrode) 02/2024
1	Transplantation 01/2023
1	Negative-Pressure Wound Therapy 10/2022
1	Length of Stay 10/2022
1	Immunotherapy 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019